ERYTECH Provides Update on the Announced Combination with PHERECYDES Post author:Cleo Sciscioli Post published:May 16, 2023 Post category:Newsroom You Might Also Like ERYTECH Announces Receipt of Nasdaq Notice October 13, 2022 ERYTECH to Present at the 2021 BIO CEO & Investor Conference February 10, 2021 ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL April 20, 2021
